AB
ISEE

Amalgamated Bank’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Amalgamated Bank’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,965
Closed -$825K – 3053
2023
Q2 		$825K Buy
20,965
+1,760
+9% +$62.1K 0.01% 1204
2023
Q1 		$467K Sell
19,205
-3,231
-14% -$70.7K ﹤0.01% 1452
2022
Q4 		$480K Buy
22,436
+3,262
+17% +$69.6K ﹤0.01% 1486
2022
Q3 		$344K Buy
19,174
+812
+4% +$10.7K ﹤0.01% 1603
2022
Q2 		$177K Buy
18,362
+3,500
+24% +$43.9K ﹤0.01% 1929
2022
Q1 		$250K Sell
14,862
-1,063
-7% -$15.7K ﹤0.01% 1850
2021
Q4 		$266K Buy
15,925
+1,327
+9% +$21.8K ﹤0.01% 1874
2021
Q3 		$237K Buy
14,598
+997
+7% +$10.8K ﹤0.01% 1931
2021
Q2 		$86K Buy
+13,601
New +$87.7K ﹤0.01% 2127

Amalgamated Bank's ISEE Position: Q3 2023 in Review

Amalgamated Bank sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 20,965 shares — an estimated $825K sold.

Amalgamated Bank first reported a position in ISEE in Q2 2021 and held it in 9 quarters. The position peaked at $825K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Amalgamated Bank reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Amalgamated Bank sold 20,965 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $825K.
  • Amalgamated Bank first reported a position in IVERIC bio, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Amalgamated Bank's IVERIC bio, Inc. Common Stock position peaked at $825K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Amalgamated Bank's 13F filing for Q3 2023, filed 8 Nov 2023.